These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11584966)

  • 21. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre.
    Song SC; Choi DW; Kow AW; Choi SH; Heo JS; Kim WS; Kim MJ
    ANZ J Surg; 2013 Apr; 83(4):268-74. PubMed ID: 22943422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy.
    Chen LP; Li C; Wang C; Wen TF; Yan LN; Li B
    Hepatogastroenterology; 2012 Sep; 59(118):1765-8. PubMed ID: 22369746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection.
    Braunwarth E; Schullian P; Kummann M; Reider S; Putzer D; Primavesi F; Stättner S; Öfner D; Bale R
    PLoS One; 2022; 17(1):e0261136. PubMed ID: 34982804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.
    Spolverato G; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Clark Gamblin T; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Tran TB; Wallis Marsh J; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):235-43. PubMed ID: 26059651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.
    Jarnagin WR; Weber S; Tickoo SK; Koea JB; Obiekwe S; Fong Y; DeMatteo RP; Blumgart LH; Klimstra D
    Cancer; 2002 Apr; 94(7):2040-6. PubMed ID: 11932907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: Factors associated with long-term outcomes.
    Si A; Li J; Xing X; Lei Z; Xia Y; Yan Z; Wang K; Shi L; Shen F
    Surgery; 2017 Apr; 161(4):897-908. PubMed ID: 27989605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models.
    Doussot A; Gonen M; Wiggers JK; Groot-Koerkamp B; DeMatteo RP; Fuks D; Allen PJ; Farges O; Kingham TP; Regimbeau JM; D'Angelica MI; Azoulay D; Jarnagin WR
    J Am Coll Surg; 2016 Sep; 223(3):493-505.e2. PubMed ID: 27296525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
    Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of resection for solitary ≤5 cm intrahepatic cholangiocarcinoma.
    Tarchi P; Tabrizian P; Prigoff J; Schwartz M
    Surgery; 2018 Apr; 163(4):698-702. PubMed ID: 29277385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
    Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.
    Okabayashi T; Yamamoto J; Kosuge T; Shimada K; Yamasaki S; Takayama T; Makuuchi M
    Cancer; 2001 Nov; 92(9):2374-83. PubMed ID: 11745293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma.
    Nakagawa T; Kamiyama T; Kurauchi N; Matsushita M; Nakanishi K; Kamachi H; Kudo T; Todo S
    World J Surg; 2005 Jun; 29(6):728-33. PubMed ID: 15880276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
    Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First and repeat liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
    Souche R; Addeo P; Oussoultzoglou E; Herrero A; Rosso E; Navarro F; Fabre JM; Bachellier P
    Am J Surg; 2016 Aug; 212(2):221-9. PubMed ID: 26552996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic resection and transplantation for peripheral cholangiocarcinoma.
    Casavilla FA; Marsh JW; Iwatsuki S; Todo S; Lee RG; Madariaga JR; Pinna A; Dvorchik I; Fung JJ; Starzl TE
    J Am Coll Surg; 1997 Nov; 185(5):429-36. PubMed ID: 9358085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
    Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
    Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.